Assessment of the efficiency of the clinical management of neuropathic pain in specialist clinics compared to general clinics in neurology health care Units in Spain;Evaluación de la eficiencia del manejo clínico del dolor neuropático en consultas especializadas frente a consultas generales en unidades asistenciales de neurología en España

Neurologia

Volumn 25, Issue 4, 2010, Pages 210-221

  Matias Guiu J ^a   Guerrero, M ^b   Lopez Trigo J ^c   Montero, J ^d   Ortega, A ^e   Alfonso, V ^f   de Salas, M ^g  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b CATHOLIC UNIVERSITY OF MURCIA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^f European Biometrics Institute   (Spain)

^g Instituto Euroclin   (Spain)

Author keywords

Cost effectiveness; Costs; General clinic; Health decision maker; Neurology; Neuropathic pain; Specialized clinic

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MANPOWER; MIDDLE AGED; NEURALGIA; NEUROLOGY; ORGANIZATION AND MANAGEMENT; PAIN; PAIN CLINIC; PATHOPHYSIOLOGY; PATIENT SATISFACTION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SPAIN; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; NEURALGIA; NEUROLOGY; PAIN; PAIN CLINICS; PATIENT SATISFACTION; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME;

EID: 77956644793     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2009.12.002     Document Type: Article

References (33)

1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.
2. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: A world health organization study in primary care. JAMA. 1998;280:147-51.
3. Bassols A, Bosch F, Campillo M, Canellas M, Banos JE. An epidemiological comparison of pain complaints in the general population of Catalonia (Spain). Pain. 1999;83:9-16.
4. Catalá E, Reig E, Artés M, Aliaga L, López JS, Segú JL. Prevalence of pain in the Spanish population: Telephone survey in 5000 homes. Eur J Pain. 2002;6:133-40.
5. IASP Task Force in Taxonomy. Pain Terms: A Current List with Definitions and Notes on Usage. En: Merksey H, Bogduk N, editores. Classification of chronic pain syndromes and definitions of pain terms. 2.a ed. Seattle: IASP Press; 1994. p. 206-13.
6. Martínez-Salio A. El papel del neurólogo en el tratamiento del paciente con dolor crónico. Rev Neurol. 2005;41:641-2.
7. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-51.
8. Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract. 2007;24:481-5.
9. Montero J, Gutiérrez E, Pardo J, Navarro C. Estudio de prevalencia, incidencia y caracterización del dolor neuropático en consultas de neurología. Estudio Prevadol. Neurología. 2005;20:385-9.
10. Galvez R, Marsal C, Vidal J, Ruiz M, Rejas J. Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions. Eur J Pain. 2007;11:244-55.
11. McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM. The burden of neuropathic pain: Results from a crosssectional survey. Eur J Pain. 2006;10:127-35.
12. Carneado-Ruiz J, Morera-Guitart J, Alfaro-Sáenz A, et al. El dolor neuropático como motivo de consulta en neurología: análisis de su frecuencia. Rev Neurol. 2005;41:643-8.
13. Problemas asistenciales. Plan estratégico nacional para el tratamiento integral de las enfermedades neurológicas. Madrid: SEN; 2002. p. 15-29.
14. Martin R, por la Comisión de Calidad de la Sociedad Valenciana de Neurología. Condiciones mínimas para la asistencia en consultas externas de Neurología. Rev Neurol. 1997;25:1135.
15. Tabernero C, Claveria E, Duarte J, Arribas A. La asistencia neurológica en los hospitales comarcales y provinciales. En Plan Estratégico Nacional para el Tratamiento integral de las enfermedades neurológicas. Madrid: Sociedad Española de Neurología; 2002. p. 31-50.
16. Morera-Guitart J, Escudero J, Aguilar M, Aguilera JM, Carnero C, Martin R, et al. Conferencia de Consenso sobre tiempos de visita en neurología: recomendaciones sobre tiempos de visita para la asistencia neurológica ambulatoria en España. Neurología. 2001;16:399-497.
17. Sociedad Española de Neurología. Tiempos de visita según niveles asistenciales. Jornada de Trabajo del Grupo de Estudio de Gestión y Asistencia en Neurología. LI Reunión Anual de la Sociedad Española de Neurología. 1999.
18. Kurtzke J. On national needs for neurologists in the United States. Neurology. 1982;36:383-8.
19. Menken M. The 1985 national ambulatory medical care survey of neurologists. Arch Neurol. 1989;43:210-3.
20. Rodríguez MJ, García AJ. A registry of the aetiology and costs of neuropathic pain in pain clinics: results of the Registry of aEtiologies and Costs (REC) in Neuropathic Pain Disorders Study. Clin Drug Invest. 2007;27:771-82.
21. Badia X, Muriel C, Gracia A, Nuñez Olarte JL, Perulero N, Gálvez R, et al. Grupo Vesbpi. Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica. Med Clin (Barc). 2003;120:52-9.
22. Stewart AL, Greenfield S, Hays RD,Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical Outcomes Study. JAMA. 1989;262:907-13.
23. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-70.
24. The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
25. Badia X, Roset M, Montserrat S, Herdman M, Segura A. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc). 1999;112 Supl 1:79-85.
26. Ruiz MA, Pardo A, Rejas J, Soto J, Villasante F, Aranguren JL. Development and Validation of the Treatment Satisfaction with Medicines Questionnaire, 2008 (SATMED-Q)© Value Health. doi:10.1111/j.1524-4733.2008.00323.x.
27. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia. 1996;16:231-8.
28. Catálogo de Especialidades Farmacéuticas 2008. Consejo General de Colegios Oficiales de Farmacéuticos [citado Feb 2008]. Madrid, 2008.
29. Oblikue Consulting 2008. Base de datos de costes sanitarios 2008 [citado Feb 2008]. Disponible en: www.oblikue.com/bddcostes.
30. Greenberg PE, Arcelus A, Birnbaum HG, Cremieux PY, Le-Lorier J, Ouellette P, et al. Pharmacoeconomics and health policy. Current applications and prospects for the future. Pharmacoeconomics. 1999;16:425-32.
31. Chang K, Nash D. The role of pharmacoeconomic evaluations in disease management. Pharmacoeconomics. 1998;14:11-7.
32. Krajnik M, McCrory C, Allen S. Management strategies for neuropathic pain in different European countries. J Pain Palliat Care Pharmacother. 2007;21:49-52.
33. O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009;27:95-112.